Diffusion Pharmaceuticals' Unattributed - IV Round

Diffusion Pharmaceuticals raised a round of funding on February 11, 2010. Investors include US Office of Naval Research.

Diffusion Pharmaceuticals is a clinical-stage company developing drugs which target the unmet medical needs characterized by oxygen deprivation (hypoxia) at the cellular level. These small molecules w…

Articles about Diffusion Pharmaceuticals' Unattributed - IV Round: